Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-055724

Chairman and CEO bought 2,500 shares at $1.67 ($4,175)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2021-09-09 Purchase +2,500 $1.67 $4,175 10,873,065 D
Open-market purchases · 2,500 sh · avg $1.67 · $4,175
Loading xslF345X03/doc4.xml…